Hurd D D
Postgrad Med. 1983 May;73(5):217-9, 222-7, 231. doi: 10.1080/00325481.1983.11697840.
The chronic leukemias have an annual incidence in the United States of about 12,000 cases. The most common types are chronic myelogenous leukemia (CML) and chronic lymphocytic leukemia (CLL). Less common are hairy cell leukemia (HCL) and prolymphocytic leukemia (PLL). All forms have an insidious onset and vague, non-specific presenting symptoms, eg, fatigue, malaise, night sweats, weight loss. Chemotherapy is the initial treatment for CML and CLL; splenectomy, splenic irradiation, and leukapheresis may also be helpful. Splenectomy is the preferred treatment for HCL. Until recently all chronic leukemias have been ultimately fatal, but the new approach of allogeneic bone marrow transplantation now used in some cases of CML may prove to be curative if done before the disease has progressed too far.
在美国,慢性白血病的年发病率约为12000例。最常见的类型是慢性粒细胞白血病(CML)和慢性淋巴细胞白血病(CLL)。较少见的是毛细胞白血病(HCL)和幼淋巴细胞白血病(PLL)。所有类型起病隐匿,症状模糊、不具特异性,如疲劳、不适、盗汗、体重减轻。化疗是CML和CLL的初始治疗方法;脾切除术、脾区照射和白细胞去除术也可能有用。脾切除术是HCL的首选治疗方法。直到最近,所有慢性白血病最终都是致命的,但目前在一些CML病例中使用的异基因骨髓移植新方法,如果在疾病进展不太严重之前进行,可能证明是可治愈的。